"The 21-gene assay for women with estrogen-receptor–positive, lymph-node–negative, early-stage breast cancer is projected to be cost-effective in Japan."
Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan
H Yamauchi et al.
BMC Health Services Research 2014, 14:372
Read more here.
Showing posts with label Japan. Show all posts
Showing posts with label Japan. Show all posts
Tuesday, 16 September 2014
Tuesday, 16 April 2013
Health care lessons from Japan
"This paper is part of a series that examines the way health services are funded and delivered in other nations."
Health care lessons from Japan
N Esmail
Fraser Institute
April 2013
Read more here.
Subscribe to:
Posts (Atom)